ISSN: 2572-4118
Breast Cancer: Current Research
ºÚÁÏÍø
Terminal Breast Cancer
Search results for
Terminal Breast Cancer
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 114
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Terminal Breast Cancer
Breast cancer is a huge opponent in the world of women, but terminal cancer is something that just boggles the mind and heart of any man or woman.
Related Journals of Terminal Breast Cancer
Breast Cancer: Current Research, Advances in Cancer Prevention, Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Journal of Cancer Research and Experimental Oncology, Journal of Cancer Epidemiology, Infectious Agents and Cancer, Middle East Journal of Cancer, Current breast cancer reports
Terminal Breast Cancer
Expert PPTs
- Nilanchali Singh
Obstetrics and Gynaecology
PPT Version | PDF Version - Jun Yang
Histopathology and pathogenesis of digestive system and Female genital and breast tumors
PPT Version | PDF Version - He Wang
Cytopathology
PPT Version | PDF Version - Dr. Sarfraz Ahmad
- Lonnie Zeltzer
Dr. Lonnie Zeltzer, Director, Distinguished Professor of Pediatrics, Anesthesiology, Psychiatry and Biobehavioral Sciences
PPT Version | PDF Version - Aruna Turaka
Intensity modulated radiation therapy
PPT Version | PDF Version - Hosam A Elbaz
Characterization of the pharmacological effects of cardiac glycosides on lung epithelial cells
PPT Version | PDF Version - You Mie Lee
Cell signalling and Biochips
PPT Version | PDF Version
Speaker PPTs
- Rongtuan Lin
Modulating the Antioxidant Defences to Potentiate Oncolytic Virotherapy in Refractory Cancer Cells
| PDF Version - Ganapathi Bhat Mugulthimoole
Unmasking the masquerading cancer cells: have we made progress with the revival of immunotherapy?
| PDF Version - Moshe Giladi
Tumor Treating Fields (TTFields) induced cancer cell death may be immunogenic resulting in enhanced antitumor efficacy when combined with immune-modulating therapy
| PDF Version - Ping Yang
Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
| PDF Version - Daniel S Peiffer
Dietary consumption of black raspberries or their anthocyanin constituents alters innate immune cell trafficking in esophageal cancer
| PDF Version - Afsar Rahbar
Studies of the importance of Cytomegalovirus infection in breast cancer
| PDF Version - Mervi Siekkinen
Effect of e-feedback on knowledge about radiotherapy of breast cancer patients
| PDF Version - Inge Verbrugge
Radio-immunotherapy of cancer: Therapeutic efficacy, underlying mechanisms and potential applications
| PDF Version - Carolina Alonso-González
Melatonin sensitizes human breast cancer cells to ionizing radiation
| PDF Version - Guldeniz Karadeniz Cakmak
The importance of intraoperative ultrasound guidance to achieve negative margins for palpable and nonpalpable breast cancer
| PDF Version - Sribatsa Kumar Mahapatra
Triple ABC Technique in Clinical Assessment in Breast Cancer Diagnosis
| PDF Version - Daisuke Ota
The clinical outcome of reconstruction with tissue expander for breast cancer patients with mastectomy
| PDF Version - Nicolae Bacalbasa
The benefits of surgery for breast cancer liver metastases – a single center experience
| PDF Version - Ozlem Tokusoglu
Phenolics and Cancer
| PDF Version - Sitanshu Sekhar Lahiri
A novel oral formulation for cancer therapy, loaded in a slow release matrix for targeted delivery
| PDF Version - Stefan B Eichmüller
Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
| PDF Version - Thomas Kieber-Emmons
Developing a first in man carbohydrate mimetic peptide vaccine for cancer: A translational story
| PDF Version - Yi-Cheng Hu
Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifentreated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study
| PDF Version - Daniel H. Snyder
Breast cancer in young age (≤40 years): The University of Tennessee Medical Center at Knoxville 10 year experience
| PDF Version - Mieke Van Hemelrijck
A role for lipids and statins in breast cancer risk and prevention?
| PDF Version - Piwen Wang
Enhanced chemopreventive effect by combining Quercetin and green tea in prostate cancer
| PDF Version - Tibor Tot
Multiparameter characterization of breast carcinoma: subgross, microscopy, proteins, and genes
| PDF Version - Gaspar Banfalvi
Origin of breast cancer metastasis
| PDF Version - San Ming Wang
Unknown genetic predisposition in familial breast cancer can lie deep in family tree
| PDF Version - Vicente Marco
Changes in breast cancer pathology reports after second opinion
| PDF Version - Christopher Busby
The breast cancer epidemic: Evidence for a radiogenic cause
| PDF Version - Saroj Velamakanni
Multiparameter analysis using cell cycle biomarkers for breast cancer: Prognostic and predictive implications
| PDF Version - Benjamin Y. M. Yung
A Big Data Analysis Platform to Unveil Gene Interactions in Cancer
| PDF Version - Jalal Poorolajal
The effect of body mass index on endometrial cancer: A meta-analysis
| PDF Version - Tatiana V Macfarlane
Aspirin use and risk of Head and Neck Cancer: evidence from the INHANCE consortium
| PDF Version - Babak Behnam
SLUG and SOX9 Cooperatively Regulate Tumor Initiating Niche Factors in Breast Cancer
| PDF Version - Yosef Yarden
Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
| PDF Version - Suoqin Tang
Survivin siRNA nano particles are capable of inhibiting liver cancer cell growth both in vitro and in vivo
| PDF Version - Eli Raveh
From chromosomal instability to metastases- H19’s role in cancer progression and its clinical significance
| PDF Version - Hugo Albrecht
Towards pharmacological validation of MNKs as anti-cancer drug targets
| PDF Version - Wei Duan
Cancer stem cells targeted delivery of siRNA to overcome induced chemoresistance
| PDF Version - Lourdes Cortes Dericks
Cancer Stem Cell Markers in Lung Cancer: Proofs of Concept and Some Reservations
| PDF Version - Huidi Liu
Reduced Expression of SOX7 in Ovarian Cancer: a Novel Tumor Suppressor through the Wnt/β-catenin Signaling Pathway
| PDF Version - Isabelle De Waziers
Use of engineered mesenchymal stem cells against cancers
| PDF Version - Soha M Hamdy
Biochemical studies on the effect of turmeric on breast cancer of rats
| PDF Version - Maria da Graça Justo Araujo
Fanconi anemia: Immune deficiency and susceptibility to cancer
| PDF Version - Pi-Wan Cheng
Disregulation of Golgi localization of glycosyltransferases alters mucin O-glycosylation and survival or metastatic properties of cancer cells
| PDF Version - Sourav Sarkar
MUC1 glycopeptide based anti-cancer vaccines
| PDF Version - Medhat Faris
Patient advocacy program for breast cancer patients in the eastern province
| PDF Version - Jose Roberto Piato
Improved frozen section examination of the retroareolar margin for prediction of nipple involvement in breast cancer
| PDF Version - Ewa Maj
Antiangiogenic treatment in non-small cell lung cancer (NSCLC)
| PDF Version - James A Bonner
Anti-EGFr monoclonal antibody therapy in Head and Neck cancer
| PDF Version - Francis Mussai
Tumour arginine addiction subverts the anti-cancer immune response
| PDF Version - Saif Uddin Ahmed
Breast Cancer: Presentation & limitation oftreatment - Bangladesh perspective
| PDF Version - Punit Kaur
A Mouse Model for Triple-Negative Breast Cancer Stem Cells (TNBC-CSC) Exhibits an Aggressive Phenotype
| PDF Version - Matthew Curzon, M.D.
Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience
| PDF Version - Heather Gage
HER2+ breast cancer: Pre and post adjuvant anti-HER2 therapy era - the University of Tennessee Medical Center at Knoxville 11 year experience
| PDF Version - K Ludwig
Targeting microtentacles on circulating breast tumor cells to reduce metastasis
| PDF Version - Peter Weightman
A new approach to the diagnosis of cervical, oesophageal and prostate cancer based on a combination of infrared and terahertz techniques
| PDF Version - Fabienne Meier-Abt
Mechanisms of Early Pregnancy-Mediated Breast Cancer Protection
| PDF Version - Federico Cattin
Breast cancer: A comparison among different diagnostic and therapeutic protocols
| PDF Version - Lei Huo
Diagnostic biomarkers in metastatic breast cancer
| PDF Version - Shareef Alqahtani
Illitracy and Breast Cancer Screening Utilization: A Case Study of Saudi Women over 60 Years of Age
| PDF Version - Arghya Adhikary
PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a
| PDF Version - Amila Orucevic
Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC’s TNM staging system on overall survival of Caucasian females with breast cancer: An institution’s 10 year experience
| PDF Version - Aysegul A. Sahin
Histopathologic evaluation of breast specimens after neoadjuvant chemotherapy
| PDF Version - Phillip K. Darcy
Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic.
| PDF Version - Yvonne Paterson
HER-2/neu as a target forListeria-based cancer immunotherapy for breast cancer
| PDF Version - Caigang Liu
FSIP1: A new potential early screening marker for breast cancer
| PDF Version - Lubna Mushtaque Vohra
Metaplastic carcinoma of the breast and p16 positivity: What does it mean?
| PDF Version - Domenico Samorani
Screening of Breast Cancer from Mammography to MR Imaging
| PDF Version - Diptendra K Sarkar
Role of NFKB as a prognostic marker in breast cancer: a new tool in the horizon
| PDF Version - Sariya Mohammadi
Case Series Of Rare Breast Diseases And Their Unusual Presentation
| PDF Version - S Karthikeyan
Resveratrol modulates expression of ABC transporters in non-small lung cancer cells: Molecular docking and gene expression studies
| PDF Version - Sushmita Pathy
Role of Radiotherapy in Multidisciplinary Management of Rectal Cancers
| PDF Version - Dashrath Ram N Reddy
Role of Nutraceuticals in chemoprevention and cancer treatment
| PDF Version - Praveen Kumar Saxena
Metal Burden -Cancer
| PDF Version - Pravin D Potdar
Molecular Profiling of Cancer Cells
| PDF Version - Shaqul Qamar Wani
Cervical Cancer: An update on the guidelines for screening
| PDF Version - Amany Mohammed Shebl
Impact of nursing management protocol on radiotherapy induced git side effects (nausea, vomiting, and diarrhea) in patients with cancer
| PDF Version - Kevin Carvalho de Melo Faria
Laparoscopic Gastrectomy for Gastric Cancer Treatment: Report of an Initial Experience
| PDF Version - Peiying Yang
Role of Na, K-ATPase in Gastrointestinal Cancer
| PDF Version - Almas Okassov
Chemical modification of anticancer Parasporins for decreasing of their toxicity
| PDF Version - Alvaro Ronco
Nutriequalization: Attempting to improve survival in cancer patients through nutritional modifications
| PDF Version - Antonio Cilla
Antiproliferative effect of main dietary phytosterols and/or β-cryptoxanthin in human colon cancer Caco-2 cells through cytosolic Ca2+ - and oxidative stress-induced apoptosis
| PDF Version - Mirette Hanna
LOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
| PDF Version - Vineeta Deshmukh
Effectiveness of Ayurvedic treatment in alleviating side-effects of radiotherapy in oropharyngeal cancer patients and its relationship with improvement in immune status of the host
| PDF Version - Mingsong Wu
Identification of differentially expressed genes in human lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene
| PDF Version - Dean A
Identifying physical and psycho-social issues facing breast cancer survivors after definitive treatment for early breast cancer: a nurse-led clinic model
| PDF Version - SinYoung Kim
Health beliefs and breast cancer screening among Korean immigrant women
| PDF Version - Shulamith Kreitler
Where, when and how to die: Insights into issues of critical nursing in cancer
| PDF Version - Liselotte Jakobsson
Does a salutogenic attitude increase life quality after prostate cancer treatment?
| PDF Version - Adriana Katz
Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
| PDF Version - Tamar Geiger
Genome-Scale Proteomic Profiling of Breast Cancer Progression
| PDF Version - Chien-Fu Hung
Mark cancer cells for CTL attack through coating with viral antigenic peptides CTLs kill tumor with viral peptides
| PDF Version - Rahul Purwar
Engineered T cells: Next-generation cancer immunotherapy
| PDF Version - John A. Barrett
Localized regulated expression of IL-12 as a gene therapy approach to cancer immunotherapy
| PDF Version - Tao Lu
Using VBIM technique to identify drug resistance genes in ovarian cancer
| PDF Version - Lydia Benhocine
Cancers, chemotherapies and hemodialysis: A retrospective study
| PDF Version - RanjitaPallavi
Geriatric Oncology: Caring for the older patient with cancer
| PDF Version - Lourdes Cortes-Dericks
ALDHhigh/CD44+ putative cancer stem cell population as therapeutic target in malignant pleural mesothelioma
| PDF Version - Marvellette Jackson
Epidemic of Losing Our Terminal Strands…
| PDF Version - Mark D Gorrell
The protease fibroblast activation proteinas a biomarker and therapeutic target in cancer and chronic liver injury
| PDF Version - Daniel Rotroff
Using DNA copy number aberrations in naturally occurring canine cancers to identify candidate drivers of carcinogenesis
| PDF Version - Ivan Mfouo-Tynga
Effects of SulfonatedZinc Phthalocyanine and Low Intensity Laser Irradiation in Inducing Photodynamic Damagein Breast Cancer Cells
| PDF Version - Mark Kester
Nanocolloidsfor Cancer
| PDF Version - Yajun Yi
Meta-analysis of transcriptional profiles in cancer for prognosis prediction and metastatic gene identification
| PDF Version - Vladimir Pak
Double Targeting as an Effective Anti-Cancer Strategy
| PDF Version - Luminita Castillos
Gene expression profiling for targeted cancer treatment
| PDF Version - Anton Yuryev
Construction of cancer pathways for personalized medicine
| PDF Version - Jung-Joon Min
Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
| PDF Version - Maria Paola COSTI
A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
| PDF Version - Bing Zhang
Translating multidimensional cancer omics data into biological insights
| PDF Version - Vladimir Torchilin
Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
| PDF Version - Kelvin K. Tsai
Linking tissue microarchitectures to rationalized molecular diagnostics in glandular cancers
| PDF Version - Zuping Xia
Development of Sphingosine Kinase Inhibitors for Cancer Therapy
| PDF Version - Charles F. L. Mbakaya
Elucidating the link between environment, nutrition, host immunity, AIDS and cancer as informed by selected studies in Kenya and beyond
| PDF Version